Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
2008 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Breast cancer
2019 Standout
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Octreoscan in patients with bronchial carcinoid tumours
2003
Molecular imaging in drug development
2008 Standout
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
1999 Standout
Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods
2000
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Monitoring chemotherapy and radiotherapy of solid tumors
2006
Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy
1996
Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs)
2002
PET and [18F]-FDG in oncology: A clinical update
1996
Imaging in the era of molecular oncology
2008 StandoutNature
Cushing's syndrome
2015 Standout
Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans
2007
Colonic transit studies: normal values for adults and children with comparison of radiological and scintigraphic methods
2009
Esophageal Cancer
2003 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response
2014
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities
2004
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
2004
Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas
2006
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Surgical Debulking and Intraperitoneal Chemotherapy for Established Peritoneal Metastases From Colon and Appendix Cancer
2001
Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography
2001
Epidemiology of constipation in children and adults: A systematic review
2011 Standout
Update on the treatment of neuroendocrine tumors
2003
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
1999
Neuroblastoma
2007 Standout
Revised Estimates for the Number of Human and Bacteria Cells in the Body
2016 Standout
Cushing's syndrome
2006 Standout
Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial
2004
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Measuring [18F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods
2003
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
2010 Standout
F-18 FDG Uptake in Breast Infection and Inflammation
2000
The Somatostatin Analogue Octreotide Inhibits Neuroblastoma Growth in Vivo
1999
Octreotide in the Management of Hormone-Refractory Prostate Cancer
2001
Chronic Constipation: An Evidence-Based Review
2011
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Powerful Prognostic Stratification By [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy
2006
Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial
2003
Memory--a Century of Consolidation
2000 StandoutScience
Positron Emission Tomography Using [18F]-Fluorodeoxy-d -Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
2000
Positron Emission Tomography As an Imaging Biomarker
2006
Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
2000
Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations
2000
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.
2004
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose.
1998
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.
2002
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
2003 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002
Detection of Liver Metastases From Endocrine Tumors: A Prospective Comparison of Somatostatin Receptor Scintigraphy, Computed Tomography, and Magnetic Resonance Imaging
2004
Guidelines for the management of thyroid cancer
2014 Standout
Reproducibility of metabolic measurements in malignant tumors using FDG PET.
1999
Putting the Rap on Akt
2004
Evaluation and Treatment of Functional Constipation in Infants and Children
2013 Standout
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.
2003
Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study
2004 Standout
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors.
2003
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
FDG-PET and Beyond: Molecular Breast Cancer Imaging
2005
Primary Systemic Therapy of Breast Cancer
2006
Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas
2004
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
2001
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Works of J E Westlin being referenced
Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?
1995
Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study
1994
[ 111 In-DPTA-D-Phe 1 ] - Octreotide Scintigraphy in the Management of Patients with Advanced Renal Cell Carcinoma
1999
Scintigraphic assessment of slow transit constipation with special reference to right‐ or left‐sided colonic delay
2004
Treatment of Malignant Endocrine Pancreatic Tumors with a Combination of α-Interferon and Somatostatin Analogs
2002
[PET in neuroendocrine tumors].
1998
[111In-DTPA-D-Phe1]-octreotide scintigraphy in patients with hormone-refractory prostatic adenocarcinoma can predict therapy outcome with octreotide treatment: a pilot study.
1998
Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy.
1995
Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers.
1995